Université de Genève;Universidade Estadual Paulista Julio de Mesquita Filho
发明人:
SALDANHA, Luiz Leonardo,BOSQUEIRO, Anne Lígia Dokkedal,BOSQUEIRO, José Roberto,HENRIQUES, Nathalia Aparecida De Paula Camaforte,VAREDA, Priscilla Maria Ponce,VILEGAS, Wagner,QUEIROZ, Emerson Ferreira
申请号：
EP16906503
公开号：
EP3474840A4
申请日:
2016.06.28
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
The present invention relates to the use of cyanoglucoside according to formula (I) and formulations thereof in the prevention and/or treatment of diabetes and/or metabolic syndrome； wherein R1, R2 and R3 are independently selected from an optionally substituted mono- or di-saccharide, —O—C(O)—R4 and halogen, such as Cl, F or Br, wherein R4 is selected from H, alkyl, such as methyl, as well as tautomers, geometrical isomers, optically active forms, pharmaceutically acceptable salts and pharmaceutically active derivative thereof.
